Ascorbic acid supplementation attenuates schizophrenia‐like symptoms in an animal model induced by ketamine-Reference-Cited by-同舟云学术

Ascorbic acid supplementation attenuates schizophrenia‐like symptoms in an animal model induced by ketamine

Published:2020-11-29 Issue:1 Volume:81 Page:26-36
ISSN:0736-5748
Container-title:International Journal of Developmental Neuroscience
language:en
Short-container-title:Int. j. dev. neurosci.

Author:

Supp Angelo D.¹,Avila Silvio¹,Mastella Gustavo A.¹,Damásio Louyse¹,de Oliveira Isabela H.¹,Godoi Amanda K.¹,Michels Alander¹,Schuck Patricia F.²,Zugno Alexandra I.¹^ORCID

Affiliation:

1. Translational Psychiatry Laboratory Graduate Program in Health SciencesUniversity of Southern Santa Catarina (UNESC) Criciúma Brazil

2. School of Sciences Pontifical Catholic University of Rio Grande do Sul Porto Alegre Brazil

Funder

Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Universidade do Extremo Sul Catarinense

Publisher

Wiley

Subject

Developmental Biology,Developmental Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jdn.10058

Reference65 articles.

1. Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters.

2. A esquizofrenia e seu tratamento farmacológico;Alves C. R. R.;Estudos De Psicologia (Campinas),2001

3. Decrease in olfactory and taste receptor expression in the dorsolateral prefrontal cortex in chronic schizophrenia

4. Ascorbic acid: much more than just an antioxidant

5. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Ascorbic Acid in Adjunctive Treatment for Schizophrenia—Current State of Knowledge;Life;2024-06-28

2. A vitamina C na esquizofrenia apresenta benefício? Estudo preliminar com análise comportamental em ratos;Jornal Brasileiro de Psiquiatria;2022-07

3. Ketamine enhances dopamine D1 receptor expression by modulating microRNAs in a ketamine-induced schizophrenia-like mouse model;Neurotoxicology and Teratology;2022-05

4. Neuroinflammation and oxidative stress in schizophrenia: are these opportunities for repurposing?;Postgraduate Medicine;2021-11-26

5. Haloperidol elicits oxidative damage in the brain of rats submitted to the ketamine-induced model of schizophrenia;Brain Research Bulletin;2021-05